News Center

Find the latest information and updates from Hebebio here

Hebe Biotechnology Appoints Industry Insider Dr. Hannes Hentze as Chief Development Officer to Advance Next-Generation GLP-1 RA Weight Loss Therapy
2025-04-09 16:30
HebeBio Advances GLP-1 Research Program
2024-11-15 10:00 Singapore -- HebeBio announces significant advancements in its GLP-1 research program, demonstrating promising results in pre-clinical studies. Read more...

Interested in opportunities with Hebebio?